Martingale Asset Management’s Akero Therapeutics AKRO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-21,260
| Closed | -$1.08M | – | 784 |
|
|
2023
Q3 | $1.08M | Buy |
21,260
+16,946
| +393% | +$857K | 0.02% | 416 |
|
|
2023
Q2 | $201K | Buy |
+4,314
| New | +$201K | ﹤0.01% | 763 |
|
|
2022
Q3 | – | Sell |
-15,316
| Closed | -$145K | – | 820 |
|
|
2022
Q2 | $145K | Sell |
15,316
-10,895
| -42% | -$103K | ﹤0.01% | 818 |
|
|
2022
Q1 | $373K | Buy |
26,211
+2,100
| +9% | +$29.9K | 0.01% | 694 |
|
|
2021
Q4 | $511K | Buy |
24,111
+1,200
| +5% | +$25.4K | 0.01% | 643 |
|
|
2021
Q3 | $513K | Buy |
+22,911
| New | +$513K | 0.01% | 665 |
|
|
2021
Q2 | – | Sell |
-7,106
| Closed | -$207K | – | 822 |
|
|
2021
Q1 | $207K | Buy |
+7,106
| New | +$207K | ﹤0.01% | 817 |
|
|
2020
Q4 | – | Sell |
-26,105
| Closed | -$804K | – | 869 |
|
|
2020
Q3 | $804K | Buy |
+26,105
| New | +$804K | 0.01% | 694 |
|